BioSpace News Archive

MyoKardia, Inc., reported financial results for the first quarter ended March 31, 2020.

Celldex Therapeutics, Inc. reported business and financial highlights for the first quarter ended March 31, 2020.

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, reported its financial results for the quarter ended March 31, 2020 and maintained its full year 2020 financial guidance.

Precigen, Inc., a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, announced first quarter financial results for 2020.

Aerie Pharmaceuticals, Inc. reported financial results for the first quarter ended March 31, 2020 and provided a general business update, including the impact of the COVID-19 pandemic on company operations.

While New York, New Jersey, Connecticut, and Massachusetts have provided medical liability immunity for their doctors treating COVID-19 patients, Pennsylvania Gov. Tom Wolf has remained silent on the issue.

Newly designed powered air-purifying respirators, developed by Ford in close collaboration with 3M, are on the way to health care workers fighting COVID-19.

Intouch Group, a full-service agency network serving the pharmaceutical industry, announced a new partnership with Heart to Heart International, a global humanitarian organization focused on improving access to healthcare services.

LabMinds, the leader in Robotics and AI for solution preparation in Life Sciences, announced that their innovative Revo ® automation system has been named a winner in the prestigious 2020 Edison Awards.

The National Association of Specialty Pharmacy has announced that former interim chair of the Democratic National Committee Donna Brazile and former chairman of the Republican National Committee Michael Steele will give a joint keynote presentation on the political landscape, election 2020 and the future of their respective parties.